Predict your next investment

Aelix Therapeutics company logo
HEALTHCARE | Drug Development
aelixtherapeutics.com

See what CB Insights has to offer

Business Relationships

1

Aelix Therapeutics Partners & Customers

1 Partners and customers

Aelix Therapeutics has 1 strategic partners and customers. Aelix Therapeutics recently partnered with Gilead Sciences on October 10, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

10/18/2018

Partner

Gilead Sciences

United States

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

AELIX Therapeutics holds a worldwide , exclusive license for the development and commercialization of the HTI immunogen .

6

Date

10/18/2018

Type

Partner

Business Partner

Gilead Sciences

Country

United States

News Snippet

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

AELIX Therapeutics holds a worldwide , exclusive license for the development and commercialization of the HTI immunogen .

Sources

6

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.